Effect of Nitisinone on Aortic Stenosis Disease Progression in Patients With Alkaptonuria: An Analysis of the Suitability of Nitisinone in Alkaptonuria (SONIA) 2 Study. [PDF]
Bruce C +9 more
europepmc +1 more source
Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuria. [PDF]
Chandani HK +4 more
europepmc +1 more source
Human medicines European public assessment report (EPAR): Nitisinone MDK (previously Nitisinone MendeliKABS), nitisinone, Tyrosinemias, Date of authorisation: 24/08/2017, Revision: 3, Status: Authorised [PDF]
openaire +1 more source
SIADH as an Underrecognized Manifestation of Porphyria-like Crises in Hereditary Tyrosinemia Type 1: Clinical and Pathophysiological Insights. [PDF]
Saraceno E +8 more
europepmc +1 more source
Combined alkaptonuria and osteoporosis contributing to chronic back pain. [PDF]
Riegler A, Anand G.
europepmc +1 more source
In Vivo Confocal Microscopy and Anterior Segment Optical Coherence Tomography Features of Corneal Pseudodendritic Lesions in Hereditary Tyrosinemia Type 1. [PDF]
Bruno R +3 more
europepmc +1 more source
Drug-induced cataract: a real-world study based on the food and drug administration adverse event reporting system database. [PDF]
Cao X +5 more
europepmc +1 more source
Early-Onset Degenerative Bone Changes as a Manifestation of Alkaptonuria: A Case Report. [PDF]
Braga R, Teixeira F, Matos C.
europepmc +1 more source

